skip to main content

Amlodipine ankle oedema — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardCardiovascular TherapeuticsAmlodipine ankle oedemaGPhC CRA

A 62-year-old woman develops symmetrical ankle oedema after amlodipine is increased from 5 mg to 10 mg daily. There is no breathlessness, raised JVP or weight gain. Which mechanism best explains why adding furosemide is unlikely to solve the problem?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DPreferential arteriolar dilation raises capillary hydrostatic pressure without sodium retention

Dihydropyridine calcium-channel blockers preferentially dilate arterioles, increasing precapillary pressure and fluid movement into dependent tissues. This is fluid redistribution rather than systemic fluid overload, so loop or thiazide diuretics usually have little effect. Dose reduction, switching the calcium-channel blocker or, when otherwise indicated, use of a renin–angiotensin-system agent can reduce the oedema.

Reference: NHS SPS, Managing peripheral oedema caused by calcium-channel blockers: https://www.sps.nhs.uk/articles/managing-peripheral-oedema-caused-by-calcium-channel-blockers/